Follow-up of Patients After Total Pancreatectomy and Islet Cell Autotransplantation at Off-Site Islet Isolation Facility


 
 
 Total pancreatectomy with islet autotransplantation (TPIAT) is a definitive management for intractable pain in patients with chronic pancreatitis. Islet autotransplantation (IAT) allows for the preservation of beta-cells to prevent complications of long-term diabetes. Our study follows TPIAT recipients for up to 12 years to determine the procedure’s efficacy completed with an off-site islet isolation facility.
 
 
 
 Patient demographics, mixed meal tolerance test measures, glycosylated hemoglobin, insulin requirements, and homeostatic model assessment for insulin resistance values were collected prior to surgery and at the most recent follow-up.
 
 
 
 Forty-four patients (median age, 46.0 years; range, 20–78 years) underwent TPIAT for CP. At an overall median follow-up time of 845.5 days (range, 195–4470 days) 8 patients were insulin independent and 36 patients were insulin dependent. At the most recent follow-up, islet yield per kilogram was the strongest indicator of insulin independence. Homeostatic model assessment for insulin resistance values were comparable between insulin independent and dependent cohorts.
 
 
 
 Our long-term follow-up data suggest that IAT can effectively reduce insulin requirements and improve post-operative glycemic control.
